UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 4, 2019 (December 3, 2019)

NANOPHASE TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	0-22333	36-3687863
(State or other	(Commission	(IRS Employer
jurisdiction of	File Number)	Identification No.)
incorporation)

1319 Marquette Drive, Romeoville, Illinois 60446 

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (630) 771-6700

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Appointment of Certain Officers.

On December 3, 2019, Nanophase Technologies Corporation (the “Company”) approved changes in responsibilities and corresponding changes in title of certain officers. The title of Chief Financial Officer was added for Jess Jankowski, the Company’s President, Chief Executive Officer, Secretary and Treasurer. This change was made to reflect Mr. Jankowski’s assumption on an indefinite basis of responsibilities as the Company’s principal financial officer and principal human resources officer. In addition to his responsibilities as President, Chief Executive Officer, Secretary and Treasurer, Mr. Jankowski has served as the Company’s principal financial officer on an interim basis since April 5, 2019. The Company changed the title of Kevin Cureton to Chief Operating Officer from Chief Commercial Officer. This change was made to reflect a change in reporting structure for the Company’s manufacturing and engineering organizations, which will report to Mr. Cureton, who will direct the Company’s operations, research & development and sales & marketing functions. Biographical information regarding Messrs. Jankowski and Cureton was disclosed in Part III, Item 10 of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2018, which was filed with the Securities and Exchange Commission on April 4, 2019. Such biographical information regarding Messrs. Jankowski and Cureton is incorporated into this Item 5.02.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 4, 2019

NANOPHASE TECHNOLOGIES CORPORATION
By:	/s/ JESS JANKOWSKI
	Name: Jess Jankowski
	Title: Chief Executive Officer